Michal Wasiak

Dr. Michal Wasiak


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2020 in Polish Heart Journal
Verified
Journal Article
Closed access
MWMichal Wasiak
Michal Wasiak
MTMateusz Tajstra
Mateusz Tajstra
ŁPŁukasz Pyka
Łukasz Pyka
MGMariusz Gąsior
Mariusz Gąsior
BACKGROUND European and American guidelines for the placement of implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) in patients with heartfailure (HF) remain unchanged despite controversy and ongoing debate on the etiology of HF. However, there are limited data on the long-term follow-up in patients who received primary defibrillator therapy with regard to ischemic cardiomyopathy (ICM) and nonischemic cardiomyopathy (NICM). The prognostic significance of the etiology of HF is not well established. AIMS The aim of the study was to assess the predictive value of the cause of HF. METHODS A total of 1073 patients with the first implantation of ICD/CRT-D between January 2009 and December 2013 from the COMMIT-HF (Contemporary Modalities In Treatment of Heart Failure) registry were selected for the study. Patients were divided into 2 groups depending on the etiology of HF: ischemic (n = 705; 65.7%) and nonischemic (n = 368; 34.3%). The primary endpoint was long-term all-cause mortality. RESULTS The median follow-up was 60.5 months. The primary endpoint occurred more often in the ICM as compared with the NICM group (35.7% vs 26.6%; P = 0.008). A higher out-of-hospital mortality in patients with ICM tended to be statistically significant (15.5% vs 10.6; P= 0.05). The multivariate analysis revealed that, among others, an ischemic etiology of HF was an independent factor of long-term mortality (hazard ratio, 1.43; 95% CI, 1.30-1.81; P = 0.003). Other independent predictors for mortality are: age older than 65 years, impaired left ventricular ejection fraction, chronic kidney disease, atrial fibrillation, diabetes mellitus. CONCLUSIONS In the real-world population, significantly worse survival of patients with ICM in comparison with those with NICM is observed, and an ischemic etiology of HF is a strong independent predictor of mortality among individuals following the placement of ICD/CRT-D.

1 January 2023 in Cardiology Journal
Verified
Journal Article
Open access
PDF file
MWMichal Wasiak
Michal Wasiak
MTMateusz Tajstra
Mateusz Tajstra
DKDariusz Kosior
Dariusz Kosior
MGMariusz Gąsior
Mariusz Gąsior
Background: Recent data regarding the comparison of implantable cardioverter-defibrillator (ICD) therapy and optimal medical treatment in patients with non-ischemic cardiomyopathy has indicated no mortality benefit as a result of ICD therapy. Although the recommendations for ICD implantation did not change, it is worth noting that these findings significantly affected the daily practice of ICD implantation in Europe. Methods: To assess the effect of ICD implantation in comparison to pharmacotherapy in the non-ischemic cardiomyopathy heart failure population through a systematic review and meta-analysis of the available carefully designed prospective randomized controlled trials. Only prospective randomized controlled trials comparing ICD implantation in primary prevention vs. optimal pharmacological therapy or placebo and reporting mortality results were included in the meta-analysis. The authors have chosen to include the following trials: CAT, AMIOVIRT, DEFINITE, and DANISH. Results: A meta-analysis of pooled hazard ratios (HR) from all trials conducted on a total of 1789 patients found that ICD therapy decreased all-cause mortality in comparison to optimal pharmacological treatment, with a HR of 0.48 (95% confidence interval [CI] 0.67-1.01); p = 0.06. The data from the AMIOVIRT, DANISH, and DEFINITE trials, with a total of 1677 participants, showed a significant reduction of sudden cardiac deaths as a result of ICD implantation, with a HR of 0.48 (95% CI 0.31-0.67); p < 0.001. Conclusions: In comparison with optimal medical treatment, ICD implantation in patients with heart failure improves the long-term prognosis in terms of sudden cardiac death, with a strong tendency towards all-cause mortality reduction. (Cardiol J 2023; 30, 1: 117-124)

21 March 2026 in Medical Sciences
Verified
Journal Article
Open access
PDF file
MWMichal Wasiak
Michal Wasiak
MSMateusz Sypniewski
Mateusz Sypniewski
PDPaula Dobosz
Paula Dobosz
Maria StępieńMaria Stępień
Maria Stępień
AMAnna Michalska-Foryszewska
Anna Michalska-Foryszewska
ZKZbigniew J. Król
Zbigniew J. Król
Background: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia worldwide and has a substantial genetic component. Genome-wide association studies (GWASs) have identified more than 100 susceptibility loci; however, replication across populations remains variable, suggesting potential population-specific differences in the genetic determinants of AF. To date, no whole-genome sequencing (WGS)-based study has evaluated AF susceptibility in a Polish population. Methods: We performed WGS (mean coverage 35×) in 233 unrelated individuals recruited within the Thousand Polish Genomes Project, including 56 patients with non-valvular AF and 177 controls without AF. After quality control and linkage disequilibrium pruning within a cardiovascular gene panel, 19,395 variants were analyzed. Association testing was performed using logistic regression adjusted for age and sex, applying both false discovery rate and Bonferroni correction thresholds. Results: No variants reached statistical significance for association with AF after correction for multiple evaluation. Previously reported susceptibility loci were not replicated in this cohort. Age was strongly associated with AF risk, whereas sex showed no significant effect. Given the relatively modest sample size, the study was primarily powered to detect variants with moderate or large effect sizes; smaller genetic effects reported in large GWASs may remain undetected. Conclusions: This pilot WGS-based study provides an initial exploration of AF-associated genetic variation in a Polish population. The absence of significant associations likely reflects the importance of further investigation in larger and well-characterized Central–Eastern European cohorts before genetic risk stratification approaches can be broadly applied across populations.